• Medicine 1

    When patients are involved, medical research results become meaningful solutions

  • Medicine 2

    We provide patient input to the latest research for chronic diseases

  • Medicine 3

    Improving patient knowledge and involvement in clinical trials

#Scarfie, the Asthma UK prevention campaign for this winter
Winter time may be hard for asthma patients. Cold air can irritate airways, triggering asthma symptoms and sometimes asthma attacks. To give hints for patients to avoid cold, EFA member Asthma UK ha ...

Read more

Irish patients will not breathe smoky coal anymore
On the 5th December, the Irish National Minister for Communications, Climate Action and Environment, Denis Naughten, announced a full Smoky Coal Ban for Ireland. Bituminous, or smoky, coal creates d ...

Read more

Spanish respiratory patients can access online physiotherapy for free
EFA Member the Spanish FENAER has launched a website to support patients with pulmonary rehabilitation online and for free. The website can be opened in all devices and offers several videos, 3 minute ...

Read more

Singing Christmas carols, another way of treating respiratory diseases
Since October, Asmamadrid, part of EFA member FENAER, organizes singing workshops with the objective of improving pulmonary capacity and better oxygenation control. The activity has been very well per ...

Read more

EFA among the few patients representatives at GARD
EFA participated in the global GARD (Global Alliance against Chronic Respiratory Diseases) meeting 2017 that took place in Brussels, Belgium the 9-11 November, represented by EFA Secretary of the Boar ...

Read more

Looking for better outcomes for upper airways patients - European Rhinology Health Forum
EFA represented patients at the European Rhinology Research Forum 2017 on 9-10 November 2017, organized by the European Forum for Research and Education in Allergy and Airway diseases (EUFOREA) and&nb ...

Read more

”No perfume in public places, please”, say the Swedes
EFA member Swedish Asthma and Allergy Association celebrated this November the Non Fragance Week. Fragrances can make people with asthma or allergy get sick easier so that is why the campaign, arrange ...

Read more

EFA Finnish member also covers now rare skin diseases
EFA members have got to know the Finnish federation for being specialised in allergies and asthma. After being united with the Finnish Association for Skin Patients in March 2017, the target group of  ...

Read more

Where are we at since the IgE discovery 50 years ago?
The discovery of IgE antibody (immunoglobulin E)  50 years ago by Gunnar Johansson and Hans Bennich in Uppsala, Sweden, revolutionised our understanding of allergy and allergic asthma.  ...

Read more

What if asthma disappears with a virus? CURE, the project consortium in which EFA participates
Current treatments allow many asthma patients to control their disease. However, medicine is not yet capable of proposing a cure for asthma. Despite the many ground-breaking discoveries that have impr ...

Read more

EFA Patients at the leading respiratory (ERS) and dermatology (EADV) congresses
EFA Patients travelled in a delegation of five to the European Respiratory Congress to present our patients perspective on allergy, asthma and COPD to a public of more than 20,000 participants from in ...

Read more

Revolutionary thinking in the conception of asthma
Our knowledge of the human body has steeped in the last decades but there are foundations still escaping our understanding, asthma development being one of them. The Lancet has published a consensus o ...

Read more

A total of 4.832 signatures for Allergy and Asthma patients
The 30 September was the last day to sign #CallAllergyAsthma, the political call for European action to improve prevention, care and research on allergy and asthma. The results are impressive!  ...

Read more

EU’s future: patients have a say
EFA has participated to the ongoing discussion on the future of the European Union, a debate set back in March with the European Commission White Paper on the Future of Europe. EFA provided a formal c ...

Read more

New updates on U-BIOPRED, supported by EFA
The U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) outcomes, in which EFA contributed, have been summarised in an interview published by European Respiratory & Pulmo ...

Read more

Swedish patients ask the government to establish national goals for people with chronic diseases
¨People with chronic diseases should be high-lighted," stated the Swedish Asthma and Allergy Association towards the Swedish government. EFA member, the Swedish Asthma and Allergy Association believes ...

Read more

Bulgarian patients organise a concert to inform about of air pollution
EFA member, the Association of Bulgarians with Bronchial Asthma, Allergy and COPD (ABBA), organised on 2nd September an acoustic concert in the cave "God's eyes" under the title "Better air for better ...

Read more

MyAirCoach, at the forefront of European innovation
MyAirCoach, EFA’s smart inhaler project, has been recognised as an instrument that “provides better ways of treating asthma and helps scientists understand what is driving this growing global epidemic ...

Read more

Sign up and join the march for the more than 300 million people with Allergy and Asthma
You are still on time to join the 4,200 signatories of the Call to Action on Allergy and Asthma Sign now! http://www.callallergyasthma.eu/
Fossil fuel subsidies cost around €330 billion annually on airways diseases
A new report from the Health and Environment Alliance (HEAL), of which EFA is a member, shows that  every  year, air pollution from mostly fossil fuel combustion cuts short the lives of an e ...

Read more

What's new - Clinical trials

In August we sent our comments to the European Commission open consultation on the summary of results of clinical trials for laypersons. This consultation follows the new clinical trials regulation  ...

Read more...

Our continuous input into the information, evaluation and safety and development policies of medicines in Europe is an achievement that we celebrate, especially after the renewal of EFA membership to  ...

Read more...

Latest research - Clinical trials

EFA organised the final event of AirPROM, an EU funded project that during five years has pulled out the best knowledge of lung research in Europe to come up with a virtual model of the human lungs. E ...

Read more...

On the 9th of September, the Chair of the EFA COPD Working Group, Michael Wilken, represented COPD patients’ views on the IMI GetReal COPD case study workshop held in Frankfurt, Germany. Launched in ...

Read more...

Key Facts

4,000 clinical trials
are authorised each year in the European Economic Area (EEA)

61% of clinical trials
are sponsored by the pharmaceutical industry

39% of clinical trials
are sponsored by non-commercial sponsors, mainly academia